Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.12M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-2.09M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$8.08M
-
Number of sells
-
-28
Significant Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q4 2024
28 filings reported holding LUMO - LUMOS PHARMA INC - Common Stock as of Q4 2024.
LUMOS PHARMA INC - Common Stock (LUMO) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 8.12M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (0 shares), GOLDMAN SACHS GROUP INC (0 shares), JPMORGAN CHASE & CO (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), WELLS FARGO & COMPANY/MN (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), ADAR1 Capital Management, LLC (0 shares), TWO SIGMA INVESTMENTS, LP (0 shares), DIMENSIONAL FUND ADVISORS LP (0 shares), and Tower Research Capital LLC (TRC) (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.